| Structure | Chemical Name | CAS | MF |
|
BRITANIN
|
|
C19H26O7
|
|
British museum leather dressing
|
|
|
|
|
Bristle
|
|
|
|
(10bS)-1,2,3,3aβ,6,7,8,9,10,10aα,13,13aβ-Dodecahydro-6α-acetoxy-1,1-dimethyl-7-methylene-5H-10β,13β-epoxy-5aβ,8β-methanocyclohepta[c]furo[3,4-e][1]benzopyran-5-one
|
51419-50-2
|
C22H28O6
|
|
(10bS)-1,2,3,3aβ,6,7,8,9,10,10aα,13,13aβ-Dodecahydro-6α-acetoxy-10β-hydroxy-1,1-dimethyl-7-methylene-13-methoxy-5H-5aβ,8β-methanocyclohepta[c]furo[3,4-e][1]benzopyran-5-one
|
51424-89-6
|
C23H32O7
|
|
|
BRK, active
|
|
|
|
|
BSAA I
|
|
|
|
|
Brivax II vaccine
|
|
|
|
Brivaracetam
|
357336-20-0
|
C11H20N2O2
|
|
(4bS,8aβ,9α)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol acetate
|
60371-76-8
|
C25H38O5
|
|
(4bS,8aβ,9α)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol
|
60371-73-5
|
C23H36O4
|
|
(4bS,8aβ,9β)-4b,5,6,7,8,8a,9,10-Octahydro-1,3,4-trimethoxy-4bα,8,8-trimethyl-2-isopropyl-9-phenanthrenol
|
60371-75-7
|
C23H36O4
|
|
|
BrkA protein
|
|
|
|
|
BSAB I
|
|
|
|
BSA (BIS-TRIMETHYLSILYL-D18)
|
|
C8H3D18NOSi2
|
|
|
BSA, Biotin, SPDP
|
|
|
|
|
BSA (Bovine Serum Albumine MBG) 20 mg/ml
|
|
|
|
|
(4bS)-9α-Acetoxy-3,10β-dihydroxy-4bα,5,6,7,8,8aβ,9,10-octahydro-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione
|
|
|
|
|
(4bS)-10β-Acetoxy-4b,5,6,7,8,8aβ,9,10-octahydro-3,9α-dihydroxy-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione
|
|
|
|
(3bS)-6α-Acetoxy-7,7,10aβ-trimethyl-3bα,5aα,6,6aα,7,8,9,10,10a,10bα,10cβ,11-dodecahydro-4H-phenanthro[3,2-b:10,1-b'c']difuran-4-one
|
40776-66-7
|
C22H28O5
|
|
(4bS)-7α-Acetoxy-5,6,7,8-tetrahydro-4-hydroxy-2-(1-hydroxy-1-methylethyl)-4bα,8,8-trimethylphenanthren-3(4bH)-one
|
65714-87-6
|
C22H28O5
|
|
(4bS)-10α-Acetoxy-4b,5,6,7,8,8aβ,9,10-octahydro-3-hydroxy-4bα,8,8-trimethyl-2-isopropyl-1,4-phenanthrenedione
|
77794-82-2
|
C22H30O5
|
|
|
BrkB protein
|
|
|
|
|
BSA, chromatographically purified
|
|
|
|
|
BSA,CHICKENANTI-
|
|
|
|
BRIVUDINE
|
82768-44-3
|
C11H13BrN2O5
|
|
|
BSA, Clone: BGN/H8, Mab anti-, HRP, ELISA/IB
|
|
|
|
|
BSA, Clone: BGN/B2, Mab anti-, ELISA/IB
|
|
|
|
|
BSA, Clone: BSA-33, Mab anti-
|
|
|
|
|
BSA, Clone: BGN/D1, Mab anti-, ELISA/IB
|
|
|
|
|
BSA, COHN-Fraction V
|
|
|
|
|
BSA Derivatization Grade
|
|
|
|
|
Brk25D protein
|
|
|
|
|
BSA, FITC, SPDP
|
|
|
|
|
(10bS)-3aβ-Ethyl-2,3,3a,4,5,5aα,6,11,12,13aβ-decahydro-1H-indolizino[8,1-cd]carbazole
|
|
|
|
|
BSA fluorescein conjugate
|
|
|
|
|
BSA Fraction V, 50g
|
|
|
|
|
BSA, Fraction V, Heat Shock Isolation, OMniPur(R)
|
|
|
|
|
BSA Fraction V, chromatographically purified
|
|
|
|
|
BSA, Fraction V, Fatty Acid-Free, Nuclease- and Protease-Fre
|
|
|
|
|
BSA, Fraction V, Fatty Acid-Poor, Endotoxin-Free
|
|
|
|
|
BSA, Goat anti-
|
|
|
|
|
(4bS)-5,6,7,8,9,9aα-Hexahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulen-10(4bαH)-one
|
|
|
|
|
(4bS)-5,6,7,8,9,9aα-Hexahydro-3-methoxy-11-methyl-6β,9β-epiminobenz[a]azulen-10(4bαH)-one
|
|
|
|
|
(11bS)-1,5,6,12,13,15aβ-Hexahydro-13-methoxy-2H,4H-[1,3]dioxolo[4,5-h]indolo[7a,1-a][2]benzazepine
|
|
|
|
BSB
|
56776-28-4
|
C28H23NaO6S2
|
|
|
Bsa29 I
|
|
|
|
|
BSA I
|
|
|
|
BRL 54443
|
57477-39-1
|
C14H18N2O
|
|
BRL 22321
|
72364-91-1
|
C12H9N3O2
|
|
|
BRL-45418
|
|
|
|
BRL-37344
|
90730-96-4
|
C19H22ClNO4
|
|
|
BRL-47923
|
|
|
|
BRL-26830
|
77955-41-0
|
C19H23NO3
|
|
|
BRL-44385
|
|
|
|
BRL-7116
|
5675-94-5
|
C16H25N3O4S
|
|
|
BSA, IgG-free, Protease-free
|
|
|
|
|
BSA IN TBS- 10X SOLUTION
|
|
|
|
|
BSA-insulin-chlorin e(6) conjugate
|
|
|
|
|
BSA (10% in H2O)
|
|
|
|
|
BSA IN PBS- 10X SOLUTION
|
|
|
|
BSA(347-359), ISOTOPIC LABELED
|
|
C74H102N16O22
|
|
|
(4bS)-1,4bα,5,8,8aα,9,10,10a-Octahydro-6,7,10aα-trimethylphenanthren-3(2H)-one
|
|
|
|
|
(4bS)-1,4bα,5,8,8aα,9,10,10a-Octahydro-5β-methoxy-10aα-methylphenanthren-3(2H)-one
|
|
|
|
|
(4bS)-4b,6a,10bα,10cβ-Tetrahydro-4bβ,6aα-diacetoxybenzo[3,4]cyclobuta[1,2-a]biphenylene
|
|
|
|
|
(6bS)-6b,7aβ-Dihydro-6bβ-(4-fluorophenyl)-7H-cycloprop[a]acenaphthylene-7α-carbaldehyde
|
|
|
|
(4bS)-4b,5,6,7,8,8aβ-Hexahydro-4-hydroxy-1-methoxy-4bα,8,8-trimethyl-2-isopropyl-3,9-phenanthrenedione
|
60371-71-3
|
C21H28O4
|
|
(4bS)-4b,6,7,8,8aβ,10-Hexahydro-1,3,4-trimethoxy-4b,8,8-trimethyl-2-isopropyl-9(5H)-phenanthrenone
|
60371-72-4
|
C23H34O4
|
|
|
(4bS)-4b,9b-Dihydro-4bβ,9bβ-dimethyl[1]benzoselenopheno[3,2-b][1]benzoselenophene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-3-methoxy-11-methyl-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-3-ol
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-benzyl-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-fluoro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-2-methoxy-11-methyl-6β,9β-epiminobenz[a]azulene
|
|
|
|
(4bS)-4b,5,6,7,8,8aβ,9,10-Octahydro-3,10α-dihydroxy-2-isopropyl-4bα,8,8-trimethyl-1,4-phenanthrenedione
|
21764-41-0
|
C20H28O4
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-(cyclopropylmethyl)-6β,9β-epiminobenz[a]azulene
|
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol acetate
|
|
|
|
(4bS)-4bα,5,6,7,8,9,9aα,10-Octahydro-11-methyl-6β,9β-epiminobenz[a]azulen-10β-ol
|
51805-82-4
|
C15H19NO
|
|
|
brlA protein
|
|
|
|
|
(5bS)-5b,6,7,11bβ,12,13-Hexahydro-4,9,10-trimethoxy-5bβ,12-dimethylbenzo[c]-1,3-dioxolo[4,5-i]phenanthridin-6β-ol
|
|
|
|
|
(6bS)-6bα,8,9,9aα-Tetrahydro-8-methylacenaphth[1,2-d]isoxazole-9β-carboxylic acid methyl ester
|
|
|
|
(4bS)-4b,5,7aβ,8-Tetrahydro-6H-dibenzo[3,4:5,6]cyclohepta[1,2-b]furan-2,3,5α,8β,10,11-hexol
|
65560-07-8
|
C17H16O7
|
|
|
BSA (10 mg/ml), FITC
|
|
|
|
|
BSA (10 mg/ml), TRITC
|
|
|
|
|
BSA M I
|
|
|
|
|
(4bS)-1,2,4bβ,9bβ-Tetrahydrobenzofuro[3,2-b]benzofuran-4(3H)-one
|
|
|
|
|
BSA, Negative Control, Gold 20 nm, EM
|
|
|
|
|
BSA, Negative Control, Gold 1 nm, EM/LM/Blotting/in sito hybrid.
|
|
|
|
|
BSA, Negative Control, Gold 5 nm, LM
|
|
|
|
|
BSA,NEGATIVECONTROL,GOLD5NM:EM
|
|
|
|
|
BSA Polyclonal Antibody
|
|
|
|
|
BRLF1 protein
|
|
|
|
|
BS14a protein, Arabidopsis thaliana
|
|
|
|
|
BSA PRE DILUTED
|
|
|
|
|
BRK-1 protein
|
|
|
|
|
BSA, Rabbit anti-, Agarose
|
|
|
|
|
BSA, Rabbit anti-
|
|
|